NCT04993963

Brief Summary

To evaluate the impact of prehabilitation on quality of recovery in heart valve surgery. To evaluate the effects of Mild to moderate valvular diseases with Newyork Heart Association (NYHA) grade I and II . Previous studies were designed to target on Coronary artery bypass graft surgery (CABGs) patients no specifically heart valve surgery patients was studied so this study cover this aspect as well so from the outcomes of this study we will determine the prehabilitation effects on valvular surgery patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 5, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 6, 2021

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2021

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2021

Completed
Last Updated

October 6, 2021

Status Verified

September 1, 2021

Enrollment Period

7 months

First QC Date

August 5, 2021

Last Update Submit

September 29, 2021

Conditions

Keywords

prehabilitationquality of recoveryheart valve surgery

Outcome Measures

Primary Outcomes (2)

  • Quality of recovery

    15-item Quality of Recovery (QoR-15) is one of the standardized outcomes for assessing patient comfort after surgery. The QoR-15 score includes the items measuring pain, physical comfort, physical independence, psychological support, and emotional state. The QoR-15 score runs from 0 to 150. Higher scores indicate better Quality of life.

    After 6 weeks, 1 month after CABG

  • Clinical Frailty Score

    Frailty is a valid and clinically important construct that is recognizable by physicians. Clinical judgments about frailty can yield useful predictive information. Initial Clinical Frailty Scale assessment had access to diagnoses and assessments related to these variables and other measures of comorbidity, function, and associated features that inform clinical judgments about the severity of frailty. It was modified to a 9-point scale to include very severely frail and terminally ill. It evaluates specific domains, including comorbidity, function, and cognition, to generate a frailty score ranging from 1 (very fit) to 9 (terminally ill).

    After 6 weeks, 1 month after CABG

Study Arms (2)

Cycle Ergometery Training (Prehabilitation)

EXPERIMENTAL

Hospital-based ergometer cycling for 20 minutes (Including warm-up and cooldown) Interval training on cycle ergometer: between 40% and 60% Vo2max, perceived exertion \<13 on Borg scale

Other: Cycle Ergometery Training (Prehabilitation)

Control Standard Group

ACTIVE COMPARATOR

Breathing exercise 15 Reps and Walk (10-15 minutes)

Other: Control Standard Group

Interventions

Interval training on cycle ergometer: between 40% and 60% Vo2max, perceived exertion \<13 on Borg scale 20-30 min/session/day (intermittent of exercise 2-3 mint, followed by 1-2 min of active recovery) Cool down (5 minutes) AROM +Body stretch

Cycle Ergometery Training (Prehabilitation)

Breathing exercise 15 Reps and Walk (10-15 minutes)

Control Standard Group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients awaiting heart valve surgery for repair or replacement
  • Both gender
  • Mild to moderate valvular diseases
  • NYHA grade I and II
  • Pre-frail to moderately frail patients with a CFS of 4-6
  • Patients with an estimated 6-8 weeks of surgical waiting list time.
  • Able to perform 6MWT at baseline with RPE\<13

You may not qualify if:

  • Patients with severe left ventricular obstructive disease (severe aortic or mitral stenosis and dynamic left ventricular outflow obstruction).
  • Patients with unstable or recently unstable cardiac syndrome
  • Other than valve surgeries e.g. CABG
  • Hospitalization for arrhythmias/ congestive heart failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pakistan Institute of medical sciences (PIMS)

Islamabad, Punjab Province, 46000, Pakistan

Location

Related Publications (4)

  • Milder DA, Pillinger NL, Kam PCA. The role of prehabilitation in frail surgical patients: A systematic review. Acta Anaesthesiol Scand. 2018 Nov;62(10):1356-1366. doi: 10.1111/aas.13239. Epub 2018 Aug 10.

    PMID: 30094821BACKGROUND
  • McCann M, Stamp N, Ngui A, Litton E. Cardiac Prehabilitation. J Cardiothorac Vasc Anesth. 2019 Aug;33(8):2255-2265. doi: 10.1053/j.jvca.2019.01.023. Epub 2019 Jan 12.

    PMID: 30765210BACKGROUND
  • Steinmetz C, Bjarnason-Wehrens B, Baumgarten H, Walther T, Mengden T, Walther C. Prehabilitation in patients awaiting elective coronary artery bypass graft surgery - effects on functional capacity and quality of life: a randomized controlled trial. Clin Rehabil. 2020 Oct;34(10):1256-1267. doi: 10.1177/0269215520933950. Epub 2020 Jun 16.

    PMID: 32546065BACKGROUND
  • Norris CM, Close JCT. Prehabilitation for the Frailty Syndrome: Improving Outcomes for Our Most Vulnerable Patients. Anesth Analg. 2020 Jun;130(6):1524-1533. doi: 10.1213/ANE.0000000000004785.

    PMID: 32384342BACKGROUND

MeSH Terms

Conditions

Heart Valve Diseases

Interventions

Preoperative Exercise

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Perioperative CarePatient CareTherapeuticsSurgical Procedures, OperativeExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Mehwish Waseem, MSPT(CPPT)

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2021

First Posted

August 6, 2021

Study Start

February 1, 2021

Primary Completion

August 15, 2021

Study Completion

August 30, 2021

Last Updated

October 6, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations